According to a study conducted among veterans, traumatic brain injury may influence the risk of sleep disorders.
The researchers’ goal was to provide an overview of endpoints and outcomes in the current acute migraine clinical trial literature to facilitate the development of novel treatments.
A team of investigators sought to assess the prevalence of pre-existing sleep disorders and their relationship to disease outcomes in patients with severe COVID-19.
Researchers systematically reviewed literature to understand the performance and sensitivity of alternative sample types compared with that of nasopharyngeal swabs for the diagnosis of SARS-CoV-2.
Persistent loneliness in midlife is an independent risk factor for later dementia and Alzheimer disease.
The incidence of infection is markedly reduced once health care workers receive the second dose of an mRNA COVID-19 vaccine regimen.
For patients receiving background therapy for PAH, treatment with sotatercept results in a reduction in pulmonary vascular resistance.
Walgreens was not following U.S. government guidance on when to give second doses of COVID-19 vaccines but will start doing so after hearing from the CDC.
There may be numerous risk factors and outcomes associated with SARS-CoV-2 infection in patients with multiple sclerosis.
With cannabis in the United States becoming more widely available for medical and recreational use, some with Parkinson disease (PD) are trying cannabis to control symptoms. However, not that much is currently known about the attitudes and experiences regarding cannabis use among those with PD.